36 related articles for article (PubMed ID: 38537394)
1. Clinical applications and advances of positron emission tomography with fluorine-18-fluorodeoxyglucose (18F-FDG) in the diagnosis of liver neoplasms.
He YX; Guo QY
Postgrad Med J; 2008 May; 84(991):246-51. PubMed ID: 18508981
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
3. Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study.
Ghafouri M; Duque L; Rodriguez LP; Philbrick KL; Savica R; Pazdernik VK; Port JD; Rummans TA; Singh B
Schizophr Res; 2024 May; 267():138-140. PubMed ID: 38537394
[No Abstract] [Full Text] [Related]
4. 18F-Fluorodeoxyglucose Positron-Emission Tomography Findings with Anti-N-Methyl-D-Aspartate Receptor Encephalitis that Showed Variable Degrees of Catatonia: Three Cases Report.
Lee EM; Kang JK; Oh JS; Kim JS; Shin YW; Kim CY
J Epilepsy Res; 2014 Dec; 4(2):69-73. PubMed ID: 25625091
[TBL] [Abstract][Full Text] [Related]
5. Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET.
Lauer M; Schirrmeister H; Gerhard A; Ellitok E; Beckmann H; Reske SN; Stöber G
J Neural Transm (Vienna); 2001; 108(6):661-70. PubMed ID: 11478418
[TBL] [Abstract][Full Text] [Related]
6. Relevance of Brain
Guetta M; Kas A; Aouidad A; Soret M; Allenbach Y; Bordonné M; Oppetit A; Raffin M; Psimaras D; Cohen D; Consoli A
Front Psychiatry; 2021; 12():685711. PubMed ID: 34177668
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
Westerland O; Amlani A; Kelly-Morland C; Fraczek M; Bailey K; Gleeson M; El-Najjar I; Streetly M; Bassett P; Cook GJR; Goh V;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2558-2565. PubMed ID: 33469686
[TBL] [Abstract][Full Text] [Related]
9. Functional neuroimaging in patients with catatonia: A systematic review.
Duque L; Ghafouri M; Nunez NA; Ospina JP; Philbrick KL; Port JD; Savica R; Prokop LJ; Rummans TA; Singh B
J Psychosom Res; 2024 Apr; 179():111640. PubMed ID: 38484496
[TBL] [Abstract][Full Text] [Related]
10. The Association Between Thyroid Stimulating Hormone and Depression: A Historical Cohort Study.
Kumar R; LeMahieu AM; Stan MN; Seshadri A; Ozerdem A; Pazdernik VK; Haynes TL; Daugherty DH; Sundaresh V; Veldic M; Croarkin PE; Frye MA; Singh B
Mayo Clin Proc; 2023 Jul; 98(7):1009-1020. PubMed ID: 37419569
[TBL] [Abstract][Full Text] [Related]
11. Brain mechanisms underlying catatonia: A systematic review.
Cattarinussi G; Gugliotta AA; Hirjak D; Wolf RC; Sambataro F
Schizophr Res; 2024 Jan; 263():194-207. PubMed ID: 36404217
[TBL] [Abstract][Full Text] [Related]
12. Catatonia as Presenting Manifestation of Behavioral Frontotemporal Dementia: Insight From a PET/MRI Study.
Pompanin S; Pigato G; Roiter B; Bussè C; Cecchin D; Cagnin A
Prim Care Companion CNS Disord; 2021 Apr; 23(2):. PubMed ID: 34000159
[No Abstract] [Full Text] [Related]
13. Probable Autoimmune Catatonia With Antibodies Against Cilia on Hippocampal Granule Cells and Highly Suspicious Cerebral FDG-Positron Emission Tomography Findings.
Endres D; Prüss H; Rauer S; Süß P; Venhoff N; Feige B; Schweizer T; Nickel K; Maier S; Egger K; Domschke K; Meyer PT; Tebartz van Elst L
Biol Psychiatry; 2020 May; 87(9):e29-e31. PubMed ID: 32122620
[No Abstract] [Full Text] [Related]
14. A Metabolic Brain Pattern Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Kerik-Rotenberg N; Diaz-Meneses I; Hernandez-Ramirez R; Muñoz-Casillas R; Reynoso-Mejia CA; Flores-Rivera J; Espinola-Nadurille M; Ramirez-Bermudez J; Aguilar-Palomeque C
Psychosomatics; 2020; 61(1):39-48. PubMed ID: 31611047
[TBL] [Abstract][Full Text] [Related]
15.
Hazlett EA; Vaccaro DH; Haznedar MM; Goldstein KE
Psychiatry Res; 2019 Jan; 271():535-540. PubMed ID: 30553101
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
